Gansu Longshenrongfa Pharmaceutical Industry Co Ltd (300534) — Financial Flexibility Index
Gansu Longshenrongfa Pharmaceutical Industry Co Ltd (300534) has a Financial Flexibility Index of -0.02x as of September 2025. Free cash flow of CN¥-9.54 Million (operating CF CN¥-17.57 Million minus capex CN¥8.02 Million) represents 0% of total liabilities (CN¥567.12 Million). Check strategic asset allocation of Gansu Longshenrongfa Pharmaceutical Indu to assess the company's strategic physical and investment asset allocation.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Gansu Longshenrongfa Pharmaceutical Industry Co Ltd Financial Flexibility Index (2011–2025)
Historical Financial Flexibility Index trend for Gansu Longshenrongfa Pharmaceutical Industry Co Ltd across 15 annual periods. See Gansu Longshenrongfa Pharmaceutical Indu short-term liquidity ratio to evaluate short-term liquidity relative to the company's equity base.
Annual Financial Flexibility Index for Gansu Longshenrongfa Pharmaceutical Industry Co Ltd (2011–2025)
Year-by-year free cash flow to debt coverage for Gansu Longshenrongfa Pharmaceutical Industry Co Ltd. For the full company profile including market capitalisation, see market cap of Gansu Longshenrongfa Pharmaceutical Indu.
| Year | Flexibility Index | Free Cash Flow (CNY) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.06x | CN¥36.83 Million | CN¥-6.54 Million | CN¥613.42 Million | ▼ -83.7% |
| 2024 | 0.37x | CN¥248.36 Million | CN¥170.14 Million | CN¥674.39 Million | ▲ +3.3% |
| 2023 | 0.36x | CN¥222.89 Million | CN¥96.53 Million | CN¥625.14 Million | ▲ +113.0% |
| 2022 | 0.17x | CN¥25.05 Million | CN¥11.43 Million | CN¥149.66 Million | ▼ -70.4% |
| 2021 | 0.56x | CN¥51.55 Million | CN¥51.13 Million | CN¥91.24 Million | ▲ +16.1% |
| 2020 | 0.49x | CN¥62.05 Million | CN¥43.50 Million | CN¥127.53 Million | ▼ -38.9% |
| 2019 | 0.80x | CN¥56.73 Million | CN¥28.21 Million | CN¥71.26 Million | ▲ +253.0% |
| 2018 | 0.23x | CN¥13.01 Million | CN¥10.23 Million | CN¥57.68 Million | ▼ -70.6% |
| 2017 | 0.77x | CN¥53.67 Million | CN¥-2.05 Million | CN¥70.04 Million | ▼ -30.8% |
| 2016 | 1.11x | CN¥66.17 Million | CN¥13.14 Million | CN¥59.74 Million | ▲ +36.8% |
| 2015 | 0.81x | CN¥195.26 Million | CN¥30.60 Million | CN¥241.17 Million | ▼ -32.5% |
| 2014 | 1.20x | CN¥138.36 Million | CN¥39.01 Million | CN¥115.40 Million | ▲ +67.2% |
| 2013 | 0.72x | CN¥96.86 Million | CN¥35.92 Million | CN¥135.04 Million | ▲ +47.7% |
| 2012 | 0.49x | CN¥59.78 Million | CN¥35.62 Million | CN¥123.07 Million | ▲ +63.2% |
| 2011 | 0.30x | CN¥22.37 Million | CN¥10.16 Million | CN¥75.15 Million | — |